000163272 001__ 163272
000163272 005__ 20230915090515.0
000163272 0247_ $$2doi$$a10.1038/s41420-021-00769-6
000163272 0247_ $$2pmid$$apmid:35013121
000163272 0247_ $$2pmc$$apmc:PMC8748965
000163272 0247_ $$2altmetric$$aaltmetric:120762540
000163272 037__ $$aDZNE-2022-00052
000163272 041__ $$aEnglish
000163272 082__ $$a610
000163272 1001_ $$aZhou, Lulin$$b0
000163272 245__ $$aSenescence as a dictator of patient outcomes and therapeutic efficacies in human gastric cancer.
000163272 260__ $$aLondon$$bNature Publishing Group$$c2022
000163272 3367_ $$2DRIVER$$aarticle
000163272 3367_ $$2DataCite$$aOutput Types/Journal article
000163272 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1654865153_23357
000163272 3367_ $$2BibTeX$$aARTICLE
000163272 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000163272 3367_ $$00$$2EndNote$$aJournal Article
000163272 520__ $$aSenescence is believed to be a pivotal player in the onset and progression of tumors as well as cancer therapy. However, the guiding roles of senescence in clinical outcomes and therapy selection for patients with cancer remain obscure, largely due to the absence of a feasible senescence signature. Here, by integrative analysis of single cell and bulk transcriptome data from multiple datasets of gastric cancer patients, we uncovered senescence as a veiled tumor feature characterized by senescence gene signature enriched, unexpectedly, in the noncancerous cells, and further identified two distinct senescence-associated subtypes based on the unsupervised clustering. Patients with the senescence subtype had higher tumor mutation loads and better prognosis as compared with the aggressive subtype. By the machine learning, we constructed a scoring system termed as senescore based on six signature genes: ADH1B, IL1A, SERPINE1, SPARC, EZH2, and TNFAIP2. Higher senescore demonstrated robustly predictive capability for longer overall and recurrence-free survival in 2290 gastric cancer samples, which was independently validated by the multiplex staining analysis of gastric cancer samples on the tissue microarray. Remarkably, the senescore signature served as a reliable predictor of chemotherapeutic and immunotherapeutic efficacies, with high-senescore patients benefited from immunotherapy, while low-senescore patients were responsive to chemotherapy. Collectively, we report senescence as a heretofore unrecognized hallmark of gastric cancer that impacts patient outcomes and therapeutic efficacy.
000163272 536__ $$0G:(DE-HGF)POF4-351$$a351 - Brain Function (POF4-351)$$cPOF4-351$$fPOF IV$$x0
000163272 588__ $$aDataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
000163272 7001_ $$aNiu, Zubiao$$b1
000163272 7001_ $$aWang, Yuqi$$b2
000163272 7001_ $$aZheng, You$$b3
000163272 7001_ $$aZhu, Yichao$$b4
000163272 7001_ $$aWang, Chenxi$$b5
000163272 7001_ $$aGao, Xiaoyan$$b6
000163272 7001_ $$aGao, Lihua$$b7
000163272 7001_ $$00000-0003-3150-2751$$aZhang, Wen$$b8
000163272 7001_ $$aZhang, Kaitai$$b9
000163272 7001_ $$0P:(DE-2719)9001390$$aMelino, Gerry$$b10$$udzne
000163272 7001_ $$00000-0001-8340-6660$$aHuang, Hongyan$$b11
000163272 7001_ $$00000-0002-3762-7830$$aWang, Xiaoning$$b12
000163272 7001_ $$00000-0002-5342-0637$$aSun, Qiang$$b13
000163272 773__ $$0PERI:(DE-600)2842546-7$$a10.1038/s41420-021-00769-6$$gVol. 8, no. 1, p. 13$$n1$$p13$$tCell death discovery$$v8$$x2058-7716$$y2022
000163272 8564_ $$uhttps://pub.dzne.de/record/163272/files/DZNE-2022-00052.pdf$$yOpenAccess
000163272 8564_ $$uhttps://pub.dzne.de/record/163272/files/DZNE-2022-00052.pdf?subformat=pdfa$$xpdfa$$yOpenAccess
000163272 909CO $$ooai:pub.dzne.de:163272$$pdnbdelivery$$pdriver$$pVDB$$popen_access$$popenaire
000163272 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)9001390$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b10$$kDZNE
000163272 9131_ $$0G:(DE-HGF)POF4-351$$1G:(DE-HGF)POF4-350$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lNeurodegenerative Diseases$$vBrain Function$$x0
000163272 9141_ $$y2022
000163272 915__ $$0LIC:(DE-HGF)CCBYNV$$2V:(DE-HGF)$$aCreative Commons Attribution CC BY (No Version)$$bDOAJ$$d2021-05-04
000163272 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2021-05-04
000163272 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2021-05-04
000163272 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2021-05-04
000163272 915__ $$0StatID:(DE-HGF)0700$$2StatID$$aFees$$d2021-05-04
000163272 915__ $$0StatID:(DE-HGF)0510$$2StatID$$aOpenAccess
000163272 915__ $$0StatID:(DE-HGF)0561$$2StatID$$aArticle Processing Charges$$d2021-05-04
000163272 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bCELL DEATH DISCOV : 2021$$d2023-03-31
000163272 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2023-03-31
000163272 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2023-03-31
000163272 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal$$d2021-02-14T16:19:13Z
000163272 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ$$d2021-02-14T16:19:13Z
000163272 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bDOAJ : Blind peer review$$d2021-02-14T16:19:13Z
000163272 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2023-03-31
000163272 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2023-03-31
000163272 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2023-03-31
000163272 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences$$d2023-03-31
000163272 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bCELL DEATH DISCOV : 2021$$d2023-03-31
000163272 9201_ $$0I:(DE-2719)5000018$$kAG Nicotera$$lSynaptic Connectivity and Neurodegeneration$$x0
000163272 980__ $$ajournal
000163272 980__ $$aVDB
000163272 980__ $$aUNRESTRICTED
000163272 980__ $$aI:(DE-2719)5000018
000163272 9801_ $$aFullTexts